GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.

Tens of thousands of Zantac users have filed product liability ... Obsessed with population collapse and the moral obligation to have children, the billionaire bought adjoining mansions for ...

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

Nov. 6, 2024 — Children whose mothers took extra vitamin D during pregnancy continue to have stronger bones at age seven, according to ... Exposure to Particular Sources of Air Pollution Is ...

Millions of children have no access to education, work long hours under hazardous conditions, or have their safety and futures threatened by armed conflict. They suffer targeted attacks on their ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

As spooky season approaches, the master of children’s horror recommends creepy-crawly classics and modern thrills for young readers. A graphic novel makes a powerful case that if these two men ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...